Implication of IL-17 in Bone Loss and Structural Damage in Inflammatory Rheumatic Diseases
Proinflammatory cytokines play an important role in the systemic and focal bone loss associated with chronic inflammatory diseases. Targeting these cytokines with biologics and small molecules has led to a major improvement of the bone health of patients with inflammatory arthritis. Cytokines from t...
Main Authors: | Benoit Le Goff, Béatrice Bouvard, Thierry Lequerre, Eric Lespessailles, Hubert Marotte, Yves-Marie Pers, Bernard Cortet |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2019/8659302 |
Similar Items
-
Immunomodulation with IL-17 and TNF-α in spondyloarthritis: focus on the eye and the central nervous system
by: Elsa How Shing Koy, et al.
Published: (2021-07-01) -
Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview
by: Claudia Schinocca, et al.
Published: (2021-02-01) -
Osteoimmunology of Bone Loss in Inflammatory Rheumatic Diseases
by: Fabienne Coury, et al.
Published: (2019-04-01) -
IL-23/IL-17 INHIBITORS IN IMMUNOINFLAMMATORY RHEUMATIC DISEASES: NEW HORIZONS
by: E. L. Nasonov, et al.
Published: (2019-09-01) -
Mesenchymal Stromal Cells: Updates and Therapeutic Outlook in Rheumatic Diseases
by: Christian Jorgensen, et al.
Published: (2013-10-01)